DBC was founded in 1973 by a partnership of medical doctors with the initiative to research, develop and market quality radioimmunoassay kits and reagents. As technology in the field progressed the founders of DBC recognized the need to develop simple and non-isotopic kits for our customers. With a strong research initiative, DBC successfully converted from RIA to the ELISA and LIA technologies of today.